Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Morphosys AG O.N. (MORG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
67.70 +0.05    +0.07%
10:36:42 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE0006632003 
S/N:  663200
  • Volume: 13,051
  • Bid/Ask: 67.70 / 67.75
  • Day's Range: 67.65 - 67.75
Morphosys AG 67.70 +0.05 +0.07%

MORG Recent Sentiments

 
This page contains information on users’ sentiments for the Morphosys AG O.N. stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Mar 25, 2024 Rexhepi Nexhmedin   67.16 Apr 19, 2024 @ 67.55 +0.58%
Feb 08, 2024 Rexhepi Nexhmedin   63.72 Mar 01, 2024 @ 65.12 +2.20%
Feb 05, 2024 Trading Desk   64.26 Mar 01, 2024 @ 65.12 +1.34%
Jan 11, 2024 Ronald Pohtz   32.78 Feb 02, 2024 @ 41.30 +25.99%
Dec 21, 2023 Bertram Knobloch   32.42 Jan 12, 2024 @ 30.90 -4.69%
Dec 14, 2023 Dima Geinz   30.89 Jan 05, 2024 @ 35.00 +13.31%
Dec 11, 2023 Trading Desk   31.90 Dec 18, 2023 @ 34.74 +8.90%
Nov 21, 2023 Ronald Pohtz   15.15 Dec 15, 2023 @ 35.00 +131.02%
Nov 21, 2023 Jannik Selzer   15.20 Dec 15, 2023 @ 35.00 -130.26%
Nov 06, 2023 jordi font   30.71 Nov 30, 2023 @ 21.10 -31.29%
Aug 24, 2023 Gerhard Lukas   28.99 Nov 30, 2023 @ 21.10 -27.22%
Aug 11, 2023 Hongwen Ma   27.25 Oct 03, 2023 @ 23.50 +13.76%
Jun 15, 2023 Anil Meydan   25.94 Nov 30, 2023 @ 21.10 -18.66%
Mar 15, 2023 Marsi Mo   13.72 Apr 07, 2023 @ 17.09 +24.56%
Mar 08, 2023 Emil György   15.66 Mar 13, 2023 @ 14.74 -5.87%
Feb 21, 2023 Gerhard Lukas   17.64 Mar 17, 2023 @ 13.91 +21.15%
Jan 16, 2023 Moritz Ampenberger   16.45 Feb 10, 2023 @ 18.75 +13.98%
Jan 13, 2023 Emil György   16.61 Jan 16, 2023 @ 16.67 +0.36%
Dec 16, 2022 Gerhard Lukas   12.32 Jan 06, 2023 @ 14.08 +14.29%
Nov 18, 2022 Moritz Ampenberger   15.09 Dec 09, 2022 @ 15.95 -5.70%
Nov 14, 2022 Alexandru Cristian...   14.45 Nov 28, 2022 @ 14.54 +0.62%
Oct 25, 2022 Emil György   20.39 Oct 31, 2022 @ 19.03 -6.67%
Sep 13, 2022 Emil György   19.70 Sep 19, 2022 @ 19.40 -1.52%
Aug 26, 2022 Hasan Uzun   18.23 Aug 29, 2022 @ 17.98 -1.37%
Aug 24, 2022 Emil György   18.95 Aug 29, 2022 @ 17.98 -5.12%
Aug 04, 2022 Tom Lhok   21.20 Aug 26, 2022 @ 18.20 -14.15%
May 12, 2022 Marsi Mo   16.73 Jun 03, 2022 @ 20.17 +20.56%
Feb 17, 2022 Hongwen Ma   25.51 Mar 11, 2022 @ 23.52 +7.80%
Feb 14, 2022 Marsi Mo   26.51 Mar 11, 2022 @ 23.52 -11.28%
Feb 07, 2022 Gerhard Lukas   28.37 Mar 04, 2022 @ 22.38 -21.11%
Jan 21, 2022 Marsi Mo   28.30 Feb 11, 2022 @ 26.41 -6.68%
Jan 10, 2022 Gerhard Lukas   30.83 Feb 04, 2022 @ 28.34 -8.08%
Dec 13, 2021 Gerhard Lukas   32.88 Jan 07, 2022 @ 30.65 -6.78%
Nov 02, 2021 Rick Weidenauer   43.40 Nov 26, 2021 @ 36.40 -16.13%
Oct 15, 2021 Gerhard Lukas   39.35 Nov 05, 2021 @ 40.03 -1.73%
Sep 13, 2021 Gerhard Lukas   42.01 Oct 08, 2021 @ 39.92 -4.98%
Sep 13, 2021 Bernd Dinkel   41.84 Oct 08, 2021 @ 39.92 +4.59%
Aug 30, 2021 Just4profit   47.35 Sep 24, 2021 @ 41.99 -11.32%
Jul 28, 2021 Michael Krohn   45.35 Aug 20, 2021 @ 45.60 +0.55%
Jul 27, 2021 Hongwen Ma   43.98 Aug 20, 2021 @ 45.60 -3.68%
Jul 27, 2021 Jannik Selzer   45.05 Aug 20, 2021 @ 45.60 -1.22%
Jul 20, 2021 Matthias Karl...   54.36 Aug 13, 2021 @ 46.04 +15.31%
Jun 24, 2021 Bernd Dinkel   64.74 Jul 16, 2021 @ 57.48 -11.21%
Jun 04, 2021 Kersten Henry   68.58 Jun 25, 2021 @ 66.30 -3.32%
Apr 14, 2021 Bernd Dinkel   76.16 May 07, 2021 @ 70.90 -6.91%
Apr 06, 2021 Michael Schurm   74.54 Apr 30, 2021 @ 78.94 +5.90%
Mar 25, 2021 Dominik Path   75.50 Apr 16, 2021 @ 75.62 +0.16%
Mar 02, 2021 Bernd Dinkel   87.54 Mar 26, 2021 @ 75.80 -13.41%
Jan 25, 2021 Marcell Kästner   98.80 Feb 19, 2021 @ 88.48 -10.45%
Nov 18, 2020 Bernd Dinkel   88.32 Dec 11, 2020 @ 93.26 +5.59%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MORG Comments

Write your thoughts about Morphosys
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
gowtham kotha
gowtham kotha Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I would like to buy this. Any suggestions.
Robert Kable
Robert Kable Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Negative clinical trials results… not sure if 31% doen warranted, but good to investigate first.
gowtham kotha
gowtham kotha Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thankyou for the details. Also results shall be out tomorrow.
gowtham kotha
gowtham kotha Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let me wait and see
gowtham kotha
gowtham kotha Jun 29, 2022 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why its going down
Robert Laszlo
Robert Laszlo Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
from now it will move up above 50 ...
Fa We
Fa___We Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Obviously you were wrong.
Robert Laszlo
Robert Laszlo Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in Aug moved up over 50 and i sold all shares at 49.88... now i dont care
Bm Bendary
Bm Bendary Aug 02, 2021 7:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wounder why the stock has been hit so hard? Its almost @50% ot march last year when the entire market crashed!! I dont beleive lowering the upper limit of the FY revenue guidance is the driver. I have to say that ive not spent quality time understanding the fundamental of this company, i only strated to follow it recently. Appreciate your insights. Thanks
Doe John
Doe John Jul 26, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any idea?
Jon Lovbacka
Jon Lovbacka Jul 26, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Announced a narrowing of revenue guidance. There are better options out there, but today might be a good entry point as the negative reaction (incl. yesterday) seems excessive.
george bush
george bush Apr 21, 2021 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://ch.marketscreener.com/kurs/aktie/MORPHOSYS-AG-436425/news/COMPANY-TALK-J-J-nbsp-41-Prozent-Plus-mit-Morphosys-Wirkstoff-33013409/
george bush
george bush Apr 12, 2021 8:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong buy
george bush
george bush Mar 25, 2021 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
European approval for tafasitamab is due at the end of May
Bert Muermans
Bert Muermans Mar 15, 2021 5:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Damn good results published!!!
Bert Muermans
Bert Muermans Mar 15, 2021 1:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When (what time)  is the news public concerning their yearresults?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email